Doctor Evidence (DRE) and The Castleman Disease Collaborative Network (CDCN) Announce Collaboration

DRE will work with David C. Fajgenbaum, MD, MBA, MSc, and his team of researchers to use DRE software platforms for the COvid19 Registry of Off-label and New Agents (CORONA), in identifying and analyzing all COVID-19 treatments to prioritize clinical trials and support physicians in providing the best possible care for their patients with COVID-19

SANTA MONICA, Calif.--(BUSINESS WIRE)--In the global race to find effective treatments for COVID-19, Doctor Evidence (DRE) is collaborating with David Fajgenbaum, MD, MBA, MSc, co-founder of The Castleman Disease Collaborative Network (CDCN), and an assistant professor of Translational Medicine & Human Genetics and director of the Center for Cytokine Storm Treatment & Laboratory at the Perelman School of Medicine at the University of Pennsylvania, to help provide essential information for researchers and physicians by maintaining a central repository of current COVID-19 treatments.